Abstract
According to statistics, acute articular rheumatism has its annual curve of highest frequency at the end of October and during November. Fortunately modern therapeutics has put us in a position to cope successfully, as a rule, with the worst symptoms of the disease. Old practitioners readily admit that they no longer see the prolonged agonizing sufferings in acute rheumatism which were not infrequent thirty or forty years ago, before the introduction of the salicylates. These remedies are not a specific for the disease, but if prescribed with due reference to the indications of the individual case they give symptomatic alleviation to the majority of patients. About one in every eight cases of acute rheumatism, however, fails utterly to be relieved by the salicylates. Some of these after a period of primary relief refuse to progress beyond the slow running subacute state. A few of the obstinate cases will yield promptly
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callMore From: JAMA: The Journal of the American Medical Association
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
